Daisy Berisha
Clinical focus in primary eye care and ocular disease including diabetic eye examinations, glaucoma screenings and treatments, anterior segment disease as well as pediatric eye examinations for children aged 5 and up.<quillbot-extension-portal></quillbot-extension-portal>
Dr. Berisha takes a special interest in dry eye disease, screening and management of glaucoma and diabetic eye disease, and finding the ideal corrective eyewear for each patient.<quillbot-extension-portal></quillbot-extension-portal>
Melissa Yao
<p>Routine and Complex Cataract Surgery</p><p>Medical and Surgical Treatment of Glaucoma</p><p>Comprehensive Ophthalmology</p>
<p>Glaucoma</p><p>Resident Education</p>
<p>Wen-Jeng M. Yao, MD, is an Attending Physician and Associate Professor in Ophthalmology at Montefiore Einstein. Her clinical focus is on routine and complex cataract surgery, medical and surgical treatment of glaucoma, and comprehensive ophthalmology. She enjoys establishing long-lasting relationships with her patients, delivering the highest quality clinical and surgical care in ophthalmology, and teaching residents who are training to become future ophthalmologists.</p><p>After receiving her Bachelor of Arts degree at Cornell University, Dr. Yao attended Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, earning her Doctor of Medicine in 2006. She began her postdoctoral training with a yearlong internship at Saint Peters University Hospital, followed by her residency in ophthalmology at George Washington University in 2010. In 2011, she completed her surgical glaucoma fellowship at Columbia Presbyterian Hospital.</p><p>Dr. Yao’s research interests involve identifying epidemiological associations of glaucoma and advancing surgical and laser techniques for glaucoma therapy. Her work has been shared through peer-reviewed journals, book chapters, abstracts and poster presentations.</p><p>Dr. Yao is board certified and is a member of the American Academy of Ophthalmology and the American Glaucoma Society. She was listed as a Castle Connelly Top Doctor in 2021, 2022 and 2023.</p>
Alex B. Theventhiran
<p>Medical and surgical management of glaucoma, anterior segment surgery and complex cataracts.</p>
<p>Focus on optimization of diagnosis and treatment of glaucoma; analyzing and optimizing patient outcomes post surgery; analysis of post-operative treatment modalities; minimally invasive glaucoma surgery outcomes and analysis of post surgical findings/complication.</p>
Anurag Shrivastava
<p>Glaucoma/Anterior Segment</p>
<p>Dr. Shrivastava is fellowship trained in glaucoma, and provides comprehensive eyecare for patients primarily with anterior segment disease.</p>
<p><span style="color:red;"> </span></p><p>Dr. Shrivastava’s clinical research is primarily focused on structural and functional deficits in glaucoma, along with advancements in drug delivery and trials involving novel molecules and therapeutic targets. As the former Program Director for the Ophthalmology Residency Program, and as the current Assistant Dean for Montefiore Medical Center, Dr. Shrivastava is additionally very active in developing and researching advancements in medical educational resources.</p>
<p>Anurag Shrivastava, MD serves as Assistant Dean, Montefiore Medical Center and Associate Designated Institutional Officer, Graduate Medical Education. He is an attending physician, Glaucoma and Associate Professor, Ophthalmology and Visual Sciences at Montefiore Einstein. Dr. Shrivastava is fellowship trained in glaucoma, and provides comprehensive eye care for patients primarily with anterior segment disease.</p><p>In 1996, Dr. Shrivastava received his Bachelor of Arts in psychology and his Bachelor of Science in neuroscience from University of Rochester with high honors. He later pursued his medical education at State University of New York, Upstate Medical University, Syracuse, earning his Doctor of Medicine in 2003. After completing a transitional year internship at Weill Cornell New York Hospital Queens, Dr. Shrivastava completed his ophthalmology residency at Einstein in 2007, acting as Chief Resident in his final year. He continued his medical training with a yearlong glaucoma and advanced surgical technique fellowship at Stanford University, completing it in 2008.</p><p>Dr. Shrivastava’s clinical research is primarily focused on structural and functional deficits in glaucoma, along with the interplay between cataract surgery and glaucoma management and advancements in drug delivery and trials involving novel molecules and therapeutic targets. He is very active in developing and researching advancements in medical educational resources. Dr. Shrivastava is active in the Office for Clinical Trials, and has been highly involved in cutting edge clinical trials at the forefront of glaucoma management, including early phase drug and device trials along with sustained release drug delivery technologies.</p><p>Dr. Shrivastava has been recognized many times for his contributions to excellence at Montefiore Einstein, receiving the Montefiore Annual President’s Award in 2015 and being inducted into Leo M. Davidoff Einstein Society for highest tier of medical educators at the College of Medicine in 2022. He is a member of several professional organizations including the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology and the American Glaucoma Society.</p>
Saadia Rashid
<p>Dr. Rashid is American Academy of Ophthalmology board-certified ophthalmologist, specializing in the field of vitreo-retinal diseases. She is an expert in the repair of complex retinal detachments (including diabetic and sickle cell tractional retinal detachments), macular holes, giant retinal tears, epiretinal membranes, and dislocated lens. Her medical areas of expertise includes management of macular degeneration, diabetic retinopathy, sickle cell retinopathy and retinopathy of prematurity in premature babies. </p><p>She completed her Ophthalmology Residency at the prestigious Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston. She then completed two years surgical retina fellowship at the University of California, Davis.</p><p><span style="font-size:11.0pt;font-family:'Calibri',sans-serif;">Dr. Rashid is the lead ophthalmologist for the New York City Football Club since January 2022.</span></p><p> </p><p> </p>
<p>Dr. Rashid completed her Post-Doctoral Research Fellowship at the Schepens Eyes Research Institute, Harvard Medical School where she was involved in the study of inflammatory cytokines in ocular inflammatory diseases. Her current research interests are novel techniques in repair of macular holes.</p>
Gene Kim
<p>Medical and surgical management of glaucoma, including minimally invasive glaucoma surgery (MIGS),</p><p>Cataract surgery, including premium intraocular lenses.</p><p>Glaucoma laser procedures.</p>
<p>Safety and efficacy of minimally invasive glaucoma surgery (MIGS).</p><p>Post-operative outcomes after phacoemulsification cataract surgery.</p><p>Ocular coherence tomography (OCT) imaging in glaucoma management.</p>
<p>Gene Kim, MD, is an attending physician and Assistant Professor, Ophthalmology at Montefiore Einstein. A board-certified ophthalmologist with a clinical specialty in the treatment of glaucoma and cataracts, Dr. Kim’s focus is on the medical and surgical management of glaucoma, including minimally invasive glaucoma surgery (MIGS), cataract surgery, including premium intraocular lenses, and glaucoma laser procedures</p><p>After receiving his Bachelor of Science in biology and psychology from Duke University in 2008, Dr. Kim attended University of Michigan Medical School, earning his Doctor of Medicine in 2012. His postdoctoral training began with a transitional year internship at Oakwood Hospital, followed by ophthalmology residency training at the Baylor College of Medicine Cullen Eye Institute from 2013 to 2016. He went on to complete a yearlong glaucoma fellowship at the Columbia University Edward S. Harkness Eye Institute in 2017.</p><p>Dr. Kim’s research focuses on safety and efficacy of MIGS, post-operative outcomes after phacoemulsification cataract surgery and ocular coherence tomography (OCT) imaging in glaucoma management. He has shared his research through peer-reviewed journals, book chapters and regional and national presentations. He is also a reviewer for the <em>Journal of Glaucoma</em>.</p><p>Dr. Kim is a Diplomate of the American Board of Ophthalmology, and is a member of the American Glaucoma Society and the American Academy of Ophthalmology.</p>
Joann J. Kang
<p><span style="color:#202124;">Dr. Kang is expertly trained in all anterior segment disease and her surgical expertise includes cataract extraction, corneal transplants, secondary IOL fixation and other corneal procedures. </span></p>
<p><span style="color:#202124;">Cataract extraction, corneal transplantation, and sutured intraocular lenses.</span></p>
<p>Joann Kang, MD, is Director, Cornea and Refractive Surgery and Associate Professor, Ophthalmology & Visual Sciences at Montefiore Einstein. A well-recognized physician and surgeon, Dr. Kang is devoted to patient care, surgery, research and teaching. Her clinical and surgical expertise includes cataract surgery, full and partial thickness corneal transplantation, ocular surface surgery/reconstruction, minimally invasive glaucoma surgery (MIGS) and laser vision correction such as laser-assisted in-situ keratomileusis (LASIK) and photorefractive keratectomy (PRK).</p><p>Dr. Kang received her Bachelor of Science from Cornell University. She then pursued her Doctorate in Medicine at Columbia University, Vagelos College of Physicians and Surgeons. After completing her transitional medicine internship at Maimonides Medical Center, she completed her three-year ophthalmology residency at Illinois Eye and Ear Infirmary, University of Illinois at Chicago and was elected chief resident in her final year. Following this, she completed a corneal and external disease fellowship at the New York Eye & Ear Infirmary of Mount Sinai.</p><p>Dr. Kang’s research focus is on corneal transplantation, Boston keratoprosthesis and sutured intraocular lenses. She has numerous publications in peer-reviewed journals, book chapters, review articles and abstracts. She is an editorial board member for <em>BMC Ophthalmology and Eye Banking and Corneal Transplantation</em>. Dr. Kang lectures as an invited speaker at conferences and symposia and is involved in multiple research protocols and clinical trials.</p><p>Dr. Kang has trained and mentored many medical students and residents. She is the recipient of multiple awards in recognition of her teaching and contributions to the department of Ophthalmology & Visual Sciences at Montefiore Einstein. Dr. Kang is board certified and is a member of several professional organizations including the American Academy of Ophthalmology and the Cornea Society. She serves on national committees for the Eye Bank Association of America, the Eye and Contact Lens Association and the International Joint Commission on Allied Health Personnel in Ophthalmology. Dr. Kang is also a member of the Medical Advisory Board and the Associate Medical Director at the Eye Bank for Sight Restoration.</p>
Richard P. Gibralter
<p><span style="font-size:12.0pt;color:black;">Specializes in complex diseases of the anterior segment including</span></p><p><span style="font-size:12.0pt;color:black;">corneal diseases, cataract, and immune mediated diseases of the ocular surface.</span></p>
<p><span style="font-size:12pt;">Immune mediated corneal diseases and surgical techniques </span></p><p><span style="font-size:12pt;">of the anterior segment.</span></p>
<p>Richard P. Gibralter, MD, is an attending physician, Cornea and Refractive Surgery, Director, Medical Student Education, Ophthalmology & Visual Sciences and Associate Professor, Ophthalmology & Visual Sciences at Montefiore Einstein. Dr. Gibralter has decades of experience in managing some of the most complex eye conditions. He specializes in the diagnosis and treatment of complex diseases of the anterior segment, including corneal diseases, cataract, and immune mediated diseases of the ocular surface.</p><p>After completing his Bachelor of Arts at Amherst College, Dr. Gibralter completed his medical education at the Mount Sinai School of Medicine in 1976. He went on to the esteemed Manhattan Eye and Ear Hospital for his ophthalmology training, where he served as Chief Resident. Dr. Gibralter later completed fellowships at both the New York Eye Bank for Sight Restoration and the Manhattan Eye, Ear and Throat Hospital in 1981.</p><p>Dr. Gibralter was the Founder and Co-Director of Cataract and Corneal Associates in Manhattan where he conducted the private practice of ophthalmology for nearly forty years.</p><p>Dr. Gibralter’s research focuses on immune-mediated corneal diseases and surgical techniques of the anterior segment. He has shared his work through peer-reviewed journals, case reports, posters and lectures.</p><p>A leader in ophthalmic education and Cornea and Refractive Surgery, Dr. Gibralter has helped to train countless residents and fellows over the years at some of the most prestigious eye training programs in the country. He is a Diplomate of the American Board of Ophthalmology and has been a Fellow of the American College of Surgeons. In addition, he is a member of several professional associations including the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, the Manhattan Ophthalmological Society and serves as a Director of the Manhattan Eye and Ear Ophthalmology Foundation</p>
Roy S. Chuck
<p class="bodycopy">Dr. Roy S. Chuck is an ophthalmologist, visual scientist and geneticist known for his stem cell and dry eye research, and work in corneal restoration. He chairs Einstein’s department of ophthalmology and visual sciences, one of only a handful of Asian-Americans to hold such a post in the U.S.</p>
<p class="bodycopy"> </p>
<p class="bodycopy">He also chairs the ophthalmology department at Montefiore Medical Center, overseeing tertiary care to adult and pediatric patients with diseases of the eye, with subspecialty expertise that includes neuro-ophthalmology, plastic surgery, and retina, cornea and glaucoma services. The department maintains a program of ongoing community outreach aimed at early detection and treatment of eye diseases.</p>
<p class="bodycopy"> </p>
<p class="bodycopy">Dr. Chuck is a cornea specialist with expertise in laser techniques for refractive eye conditions. He has deep research experience and holds multiple patents. His two main areas of research are corneal stem cell surgery and dry eye, the most common global eye disease. Recently, Dr. Chuck's team developed a unique mouse model of dry eye that allows animal testing of therapies. The model employs the use of <em>botulinum</em> toxin, commonly known as "botox," to block neurotransmitters in the tear-producing lacrimal gland. The resulting dry eye closely mimics that found in humans.</p>
<p class="bodycopy"> </p>
<p class="bodycopy">Dr. Chuck is a long-time stem cell investigator in connection with corneal transplantation and sight restoration. His work includes cutting-edge corneal stem cell surgery, which has a success rate of nearly 50-percent—one of the highest for stem cell surgery. The operation is performed if the stem cell pool on the eye is wiped out through injury or a genetic condition. Without these regenerating cells, eye injuries, however small, result in opaque scars that reduce or even eliminate vision. Corneal stem cell surgery requires removing the scar tissue and transplanting donated corneal stem cells onto the eye. If successful, the introduced stem cells heal the wound and vision is restored.</p>
<p class="bodycopy"> </p>
<p class="bodycopy">At Einstein, Dr. Chuck is developing research centers focusing on ophthalmologic disorders including cataracts, ocular surface disease/dry eye, glaucoma, macular degeneration, and eye conditions associated with diabetes.</p>
surgical device development
clinical trials
<div>Dr. Chuck is a prominent stem cell and dry eye researcher. He is a cornea specialist with expertise in the field of laser techniques, including LASIK surgery, corneal replacement, stem cell surgery, and refractive eye problems. </div>
<div><br />A basic scientist as well as a clinical researcher, Dr. Chuck has helped develop a unique model of dry eye using Botox that allows for testing of preclinical therapies. He has served as principal investigator on five FDA studies of vision correction and written more than 175 peer-reviewed papers and more than 100 book chapters and abstracts. Dr. Chuck has been featured several times on ABC News and ABC’s “Good Morning America” on various eye diseases and conditions. He serves on the editorial boards of several publications, including the <em>Journal of Refractive Surgery</em> and <em>Lasers in Surgery and Medicine</em>. </div>
Refractive surgery and corneal disorders including dry eye
Corneal reconstruction and stem cell surgery, dry eye, refractive surgery
<p>Roy S. Chuck, MD, PhD, is Chairman and Professor, Ophthalmology & Visual Sciences at Montefiore Einstein. Dr. Chuck’s clinical focus is in cornea and external diseases as well as refractive surgery.</p><p>After earning his Bachelor of Science in engineering at University of California, Berkeley, in 1986, Dr. Chuck attended Columbia University, earning his Doctor of Medicine and Doctor of Philosophy in 1993. He started his postdoctoral training at St. Mary’s Health Center, completing a yearlong internship in internal medicine in 1994. From then until 1998, he pursued a residency in ophthalmology at Washington University and Barnes Hospital, acting as chief resident in his final year. In 1999, he completed a yearlong fellowship in cornea and refractive surgery at Doheny Eye Institute, University of Southern California.</p><p>Dr. Chuck’s research has been published in numerous peer-reviewed journals as well as shared through many abstracts, book chapters and podium and poster presentations. He has been an editor and served on the editorial boards of many publications including the <em>Lasers in Surgery and Medicine, Journal of Refractive Surgery, Current Opinion in Ophthalmology and BMC Ophthalmology</em>. He currently serves as the Editor-in-Chief of the major journal <em>ARVO Translational Vision Science and Technology</em> and is a member of the NIH National Eye Institute Council of Editors.</p><p>Dr. Chuck is board certified and is a member of many local, national and international professional societies including the International Society for Refractive Surgery, the American Society for Laser Medicine and Surgery, and the Manhattan Ophthalmological Society. He currently serves as Secretary for Quality of Care for the American Academy of Ophthalmology.</p>